Company Filing History:
Years Active: 2001
Title: The Innovative Contributions of Claire Marie Fraser
Introduction
Claire Marie Fraser is a prominent inventor based in Potomac, MD (US). She has made significant contributions to the field of genomics, particularly in the study of Mycobacterium tuberculosis. Her work has implications for both clinical treatment and public health.
Latest Patents
Fraser holds a patent for her invention titled "DNA sequences for strain analysis in Mycobacterium tuberculosis." This innovative methodology allows for the genetic classification of different populations of the tuberculosis bacterial pathogen and related Mycobacteria. The patent discloses previously unrecognized points of variability in the Mycobacterium genome. This variability is crucial for clinicians to accurately identify isolates responsible for individual cases of disease or outbreaks, thereby guiding appropriate treatment protocols.
Career Highlights
Claire Fraser is associated with The Institute for Genomic Research, where she has been instrumental in advancing genomic research. Her expertise in microbial genomics has positioned her as a leader in the field, contributing to a better understanding of infectious diseases.
Collaborations
Fraser has collaborated with notable colleagues, including Robert D. Fleischmann and Owen Richardson White. These partnerships have further enhanced her research and the impact of her inventions.
Conclusion
Claire Marie Fraser's innovative work in the field of genomics, particularly her patent related to Mycobacterium tuberculosis, showcases her significant contributions to science and medicine. Her efforts continue to influence the way infectious diseases are understood and treated.